Similar articles

• Measuring persistency and intraocular pressure-controlled days in patients receiving topical glaucoma medications.

  Schwartz GF, Platt R. Schwartz GF, et al. Am J Manag Care. 2002 Aug;8(10 Suppl):S278-80. Am J Manag Care. 2002. PMID: 12188171
• Use of eyedrops in glaucoma: how can we help to reduce non-compliance?

  Chawla A, McGalliard JN, Batterbury M. Chawla A, et al. Acta Ophthalmol Scand. 2007 Jun;85(4):464. doi: 10.1111/j.1600-0420.2007.00882.x. Epub 2007 Feb 6. Acta Ophthalmol Scand. 2007. PMID: 17286557 No abstract available.
• Persistency with glaucoma medication.

  Fiscella RG. Fiscella RG. Am J Ophthalmol. 2004 Dec;138(6):1093-4; author reply 1094. doi: 10.1016/j.ajo.2004.05.002. Am J Ophthalmol. 2004. PMID: 15629333 No abstract available.
• [Glaucoma--strategy of treatment].

  Stefan C, Selaru D, Stefaniu I, Dumitrică DM. Stefan C, et al. Oftalmologia. 2008;52(3):3-6. Oftalmologia. 2008. PMID: 19149110 Review. Romanian. No abstract available.
• [Drug therapy in the treatment of glaucoma].

  Thieme H. Thieme H. Klin Monbl Augenheilkd. 2006 Sep;223(9):R73-8; quiz R79-80. doi: 10.1055/s-2006-924643. Klin Monbl Augenheilkd. 2006. PMID: 16986080 Review. German. No abstract available.